Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65

ClinicalTrials.gov ID: NCT03680040

Public ClinicalTrials.gov record NCT03680040. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 4:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective Non-randomized Single Arm Multi-center Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65 (RESILIENCE Trial)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this observational trial is to determine time to valve failure due to valve deterioration requiring re-intervention and collect/investigate early potential predictors of valve durability (e.g., calcification and hemodynamic deterioration) in RESILIA tissue valves.

Study identification

NCT ID
NCT03680040
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Edwards Lifesciences
Industry
Enrollment
110 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 5, 2018 (Actual)
Primary completion
Feb 13, 2024 (Actual)
Completion
Feb 13, 2024 (Actual)
Last update posted
May 9, 2024

2018 – 2024

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
University of Southern California Los Angeles California 90033 —
University of Florida - Shands Hospital Gainesville Florida 32608 —
University of Maryland, Baltimore Baltimore Maryland 21201 —
Columbia University Medical Center-NY Presbyterian Hospital New York New York 10032 —
Weill Cornell - NYC New York New York 10065 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Pinnacle Health Mechanicsburg Pennsylvania 17050 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Baylor College of Medicine - St. Luke's Hospital Houston Texas 77030 —
The Heart Hospital of Baylor Plano Plano Texas 75093 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03680040, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2024 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03680040 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →